These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 35148779)

  • 1. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey.
    Cooper-Ohm S; Habecker P; Humeniuk R; Bevins RA
    Harm Reduct J; 2024 Feb; 21(1):37. PubMed ID: 38336722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
    Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
    Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
    Ericson ØB; Eide D; Lobmaier P; Clausen T
    Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention.
    Saleem HT; Likindikoki S; Nonyane BAS; Mbwambo J; Latkin C
    Int J Drug Policy; 2021 Oct; 96():103287. PubMed ID: 33994309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
    Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
    J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
    Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
    Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
    Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
    Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
    Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
    Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
    J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of paying people who use drugs cash to distribute naloxone within their networks.
    Lewis NM; Smeltzer RP; Baker TJ; Sahovey AC; Baez J; Hensel E; Poole B; Stewart C; Cogan AG; Bullard M; Taylor JL
    Harm Reduct J; 2024 Feb; 21(1):42. PubMed ID: 38365734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to, Experience with, and Attitudes towards Take Home Naloxone: An Online Survey.
    Schwieger L; Carpenter JE; Moran TP; Erowid F; Cornelison M; Evans D; Morgan B; Murray BP
    J Community Health; 2024 Jun; 49(3):526-534. PubMed ID: 38127295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids.
    Gicquelais RE; Bohnert ASB; Fernandez AC
    Subst Abus; 2021; 42(3):372-376. PubMed ID: 32692621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.